[The influence of 2-(1,2,3,4-tetrahydroxy-1-naphthylamino)-2-imidazoline hydrochloride on intraocular pressure and conjunctival hyperemia of the human eye].
D000293:Adolescent; D000328:Adult; D000368:Aged; D001762:Blepharitis / Q000150:complications; D002648:Child; D003228:Conjunctiva / Q000098:blood supply / Q000187:drug effects*; D003231:Conjunctivitis / Q000188:drug therapy; D005128:Eye Diseases / Q000188:drug therapy*; D005901:Glaucoma / Q000188:drug therapy; D006801:Humans; D006940:Hyperemia / Q000188:drug therapy; D007093:Imidazoles / Q000494:pharmacology / Q000627:therapeutic use*; D007429:Intraocular Pressure / Q000187:drug effects*; D008875:Middle Aged; D009281:Naphthalenes / Q000494:pharmacology / Q000627:therapeutic use; D013566:Sympathomimetics / Q000494:pharmacology / Q000627:therapeutic use*; D014065:Tonometry, Ocular; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D007093:Imidazoles; D009281:Naphthalenes; D013566:Sympathomimetics; D014662:Vasoconstrictor Agents
Der Einfluss des 2-(1,2,3,4-Tetrahydro-1-naphthylamino)-2-imidazolin-hydrochlorid auf den intraocularen Druck und die Bindehauthyperämie des menschlichen Auges.